For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs—commonly referred to as antiretroviral therapy—the virus usually rushes ...
Originally, when [HIV/AIDS] came out, it was so stigmatized. People were so fearful. We know people that have died from it, but we know people who have survived and they’re living very normal lives.
This the second case reported this month, with the initial cases in the outbreak being reported back in November of 2023.
The Western North Carolina AIDS Project's annual Dining Out for Life event is fast approaching. At the end of April, ...
Reality TV stars are taking their platforms to Capitol Hill as cuts to HIV drug assistance programs threaten access to ...
Zoliflodacin and gepotidacin make oral therapy viable again for urogenital gonorrhea, yet lower pharyngeal efficacy and weak resistance surveillance mean clinicians must adopt cautious, targeted use.
Africa carries a disproportionate share of the global hepatitis B virus (HBV) burden.1 An estimated 64·7 million people in Africa are living with chronic HBV infection—a condition associated with high ...
Latent HIV-1 reservoirs are a major barrier to curing HIV because the virus can hide silently inside cells for years. In a laboratory model of HIV ...
The MarketWatch News Department was not involved in the creation of this content. Strategy May Bolster Blood Cancer Therapy and Move HIV Research Closer to a Cure BRONX, N.Y., March 13, 2026 ...
US-supported international HIV research, particularly that conducted in African countries, has direct benefits to Americans. Cuts to that research may undermine those benefits.
Many changes regarding Delaware's Ryan White HIV/AIDS Program are slated to take effect April 1. Here's what you need to know ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results